Skip to main content

The rockefeller university

News & HighlightsNews
Scientists are using ‘elite’ antibodies from COVID-19 survivors to develop potent therapies

Most people infected with the coronavirus are able to fight it off because their immune system produces effective antibodies. Rockefeller scientists are working to turn such antibodies into a drug.

Study captures the molecular architect of cells’ infrastructure
Using atomic-resolution technology, scientists have constructed the most detailed view yet of the molecular complex that decides where microtubules form.
New faculty member designs chemical probes to dissect and alter immune protein function
Ekaterina Vinogradova, an organic chemist, investigates the functions of immune proteins, with the goal of finding new targets for therapies. She will join Rockefeller as an assistant professor on January 1, 2021.
Researcher studying the dynamics of gene activity, cell by cell, joins Rockefeller faculty
Junyue Cao examines patterns of gene expression in order to better understand how cells differentiate into distinct types and how the body’s organs maintain stable populations of cells throughout life. He will move to Rockefeller as an assistant professor this summer.
Stavros Niarchos Foundation donates $3 million to Rockefeller COVID-19 research
The grant bolsters Rockefeller’s round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
3D imaging of blood vessels could shed new light on cardiovascular disease
The new imaging technique enables researchers to construct a comprehensive image of blockages and other vascular injuries.
The Rockefeller University releases statement concerning Knut Wittkowski
The opinions that have been expressed by Knut Wittkowski, discouraging social distancing in order to hasten the development of herd immunity to the novel coronavirus, do not represent the views of The Rockefeller University, its leadership, or its faculty.
Rockefeller scientists launch a broad range of studies into novel coronavirus
Over 130 scientists in 18 labs are conducting research to advance the development of new, urgently needed approaches for the prevention and treatment of COVID-19.
Elaine Fuchs awarded 2020 Canada Gairdner International Award for Biomedical Science
Fuchs, a world leader in the study of skin biology, is being recognized for revealing the molecular mechanisms by which skin stem cells make and repair tissues.
How skin cells embark on a swift yet elaborate death
Scientists have identified the mechanism that allows skin cells to sense changes in their environment, and very quickly respond to reinforce the skin's outermost layer. The findings provide insight into how errors in this process might lead to skin conditions like psoriasis.  
View
View